Literature DB >> 27624570

Antibiotic prescriptions for suspected respiratory tract infection in primary care in South America.

Gloria Cordoba1, Lidia Caballero2, Håkon Sandholdt3, Fátima Arteaga4, Monica Olinisky5, Luis Fabián Ruschel6, Marjukka Makela7, Lars Bjerrum3.   

Abstract

OBJECTIVES: To describe and compare antibiotic prescribing patterns for primary care patients with respiratory tract infections (RTIs) in four South American countries.
METHODS: This was a prospective observational study. General practitioners (GPs) from Argentina, Bolivia, Paraguay and Uruguay registered data about all consultations of patients with suspected RTIs in the winter of 2014 (June-August). Variation in antibiotic prescriptions was assessed using a two-level hierarchical logistic model.
RESULTS: Participating GPs (n = 171) registered 11 446 patients with suspected RTI; 3701 (33%) of these received an antibiotic prescription. There was a wide variation across countries in the use and selection of antibiotics. For example, 94% of patients with acute bronchitis were prescribed antibiotics in Bolivia, while in Uruguay only 21% received antibiotics. Amoxicillin was the most commonly prescribed antibiotic across countries, but prescription rates varied between 45% in Bolivia and 69% in Uruguay. Compared with the overall mean prescribing rate, and after adjusting for clinical presentation and demographics, prescribing of antibiotics varied by a factor of 6, the OR ranging from 0.37 (95% CI = 0.21-0.65) in Uruguay to 2.58 (95% CI = 1.66-4) in Bolivia.
CONCLUSIONS: The large variation in use and selection of antibiotics across countries is not explained by different patient populations. It could be explained by diagnostic uncertainty and contextual characteristics beyond clinical practice. Reducing uncertainty and country variation requires greater support from the healthcare systems by providing GPs with evidence-based guidelines and tools to apply them.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27624570     DOI: 10.1093/jac/dkw370

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Inadequate knowledge on appropriate antibiotics use among clients in the Moshi municipality Northern Tanzania.

Authors:  Erick Alexander Mboya; Matthew Lee Davies; Pius Gerald Horumpende; James Samwel Ngocho
Journal:  PLoS One       Date:  2020-09-24       Impact factor: 3.240

2.  General Practitioners' Views on the Acceptability and Applicability of Using Quality Indicators as an Intervention to Reduce Unnecessary Prescription of Antibiotics in Four South American Countries.

Authors:  Inés Urbiztondo; Sandi Michele de Oliveira; Nieves Hernández-Flores; Lidia Caballero; Miguel Angel Suarez; Lars Bjerrum; Gloria Cordoba
Journal:  Antibiotics (Basel)       Date:  2018-07-05

3.  Factors associated with antibiotic prescribing in patients with acute respiratory tract complaints in Malta: a 1-year repeated cross-sectional surveillance study.

Authors:  Erika A Saliba-Gustafsson; Alexandra Dunberger Hampton; Peter Zarb; Nicola Orsini; Michael A Borg; Cecilia Stålsby Lundborg
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

4.  Reducing unnecessary antibiotic prescription through implementation of a clinical guideline on self-limiting respiratory tract infections.

Authors:  Xavier Sánchez; María Orrico; Toa Morillo; Andrea Manzano; Ruth Jimbo; Luciana Armijos
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

5.  Knowledge, Attitudes and Practices in Antibiotic Use in Family Medicine Students.

Authors:  Xavier Sánchez; Andrea Landázuri; Paulina Londo; Andrea Manzano; Andrés Moreno Roca; Ruth Jimbo
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

6.  "Appropriateness and adequacy of antibiotic prescription for upper respiratory tract infections in ambulatory health care centers in Ecuador".

Authors:  Xavier Sánchez Choez; María Luciana Armijos Acurio; Ruth E Jimbo Sotomayor
Journal:  BMC Pharmacol Toxicol       Date:  2018-07-27       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.